Bauer Adrian, Diez Claudius, Schubel Jens, El-Shouki Nagi, Metz Dietrich, Eberle T, Hausmann Harald
Department of Cardiovascular Technology, MediClin Heart Centre Coswig, Sachsen Anhalt, Germany.
J Extra Corpor Technol. 2010 Mar;42(1):30-9.
Minimized extracorporeal circulation (MECC, Maquet, Cardiopulmonary AG, Hirrlingen, Germany) is an established procedure to perform coronary revascularization. Studies showed positive effects of MECC compared to conventional cardiopulmonary bypass (CCPB) procedures in terms of transfusion requirements, less inflammation reactions, and neurological impairments. Recent retrospective studies showed higher mean arterial pressure (MAP) and a lower frequency of vasoactive drug use. We addressed this issue in this study. The hypothesis was to find a higher MAP during coronary bypass grafting surgery in patients treated with MECC systems. We performed a prospective, controlled, randomized trial with 40 patients either assigned to MECC (n = 18) or CCPB (n = 22) undergoing coronary bypass grafting. Primary endpoints were the perioperative course of mean arterial pressure, and the consumption of norepinephrine. Secondary endpoints were the regional cerebral and renal oxygen saturation (rSO2) as an indicator of area perfusion and the course of hematocrit. Clinical and demographic characteristics did not significantly differ between both groups. Thirty-day mortality was 0%. At four of five time points during extracorporeal circulation (ECC) MAP values were significantly higher in the MECC group compared to CCPB patients (after starting the ECC 60 +/- 11 mmHg vs. 49 +/- 10 mmHg, p = .002). MECC patients received significantly less norepinephrine (MECC 22.5 +/- 35 microg vs. CCPB 60.5 +/- 75 microg, p = .045). The rSO2 measured at right and left forehead and the renal area was similar for both groups during ECC and significantly higher at CCPB group 1 and 4 hours after termination of CPB. Minimized extracorporeal circulation provides a higher mean arterial pressure during ECC and we found a lower consumption of vasoactive drugs in the MECC group. There was a decrease in regional tissue saturation at 1 and 4 hours post bypass in the MECC group possibly due to increased systemic inflammation and extravascular fluid shift in the CCPB group.
微创体外循环(MECC,迈柯唯,德国希灵根心肺股份公司)是一种用于进行冠状动脉血运重建的既定术式。研究表明,与传统心肺转流(CCPB)术式相比,MECC在输血需求、较少的炎症反应和神经功能损害方面具有积极效果。近期的回顾性研究显示,MECC患者的平均动脉压(MAP)更高,血管活性药物的使用频率更低。我们在本研究中探讨了这一问题。我们的假设是,在接受MECC系统治疗的患者进行冠状动脉搭桥手术期间,能发现更高的MAP。我们对40例接受冠状动脉搭桥手术的患者进行了一项前瞻性、对照、随机试验,这些患者被随机分为MECC组(n = 18)或CCPB组(n = 22)。主要终点是平均动脉压的围手术期过程以及去甲肾上腺素的消耗量。次要终点是作为区域灌注指标的局部脑和肾氧饱和度(rSO2)以及血细胞比容的变化过程。两组患者的临床和人口统计学特征无显著差异。30天死亡率为0%。在体外循环(ECC)期间的五个时间点中的四个时间点,MECC组的MAP值显著高于CCPB组患者(开始ECC后60±11 mmHg对49±10 mmHg,p = 0.002)。MECC组患者接受的去甲肾上腺素显著更少(MECC组22.5±35μg对CCPB组60.5±75μg,p = 0.045)。在ECC期间,两组在右前额、左前额和肾区测量的rSO2相似,而在CPB结束后1小时和4小时,CCPB组的rSO2显著更高。微创体外循环在ECC期间可提供更高的平均动脉压,并且我们发现MECC组血管活性药物的消耗量更低。MECC组在搭桥术后1小时和4小时局部组织饱和度下降,这可能是由于CCPB组全身炎症增加和血管外液体转移所致。